Cardiac Amyloidosis: Current Insights from Patients and Cardiologists Journeying Together
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Cardiac Failure"
DOI: 10.1016/j.cardfail.2019.07.258
Abstract: Introduction Cardiac amyloidosis (CA) can be difficult to diagnose, with a prolonged and often complex patient journey. The most common forms of CA include light-chain (AL) amyloidosis and transthyretin amyloidosis (hereditary or wild-type). The introduction… read more here.
Keywords: patients cardiologists; insights patients; amyloidosis current; cardiac amyloidosis ... See more keywords
Bad players in AL amyloidosis in the current era of treatment
Sign Up to like & getrecommendations! Published in 2023 at "Expert Review of Hematology"
DOI: 10.1080/17474086.2023.2166924
Abstract: ABSTRACT Introduction Systemic AL amyloidosis (ALA) is a clonal plasma cell (PC) disease characterized by deposition of amyloid fibrils in different organs and tissues. Traditionally, the prognosis of ALA is poor and is primarily defined… read more here.
Keywords: current era; players amyloidosis; bad players; era ... See more keywords
Noninvasive Diagnostics of Renal Amyloidosis: Current State and Perspectives
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms232012662
Abstract: Amyloidoses is a group of diseases characterized by the accumulation of abnormal proteins (called amyloids) in different organs and tissues. For systemic amyloidoses, the disease is related to increased levels and/or abnormal synthesis of certain… read more here.
Keywords: renal amyloidosis; current state; noninvasive diagnostics; diagnostics renal ... See more keywords